Dr. Keiji Terao, President and CEO of CycloChem Bio Co., Ltd., has been featured as a "Top Chemical Innovation CEO 2026" in the CXO Award feature published by Business Management Review.

Business Management Review is an international online business publication covering corporate management, leadership, and technological innovation.

The article highlights CycloChem Bio’s commitment to "transforming science into social value" through in-depth research into the unique properties of cyclodextrin and the application of this scientific knowledge to practical solutions in the healthcare, food, and wellness industries.

The interview article can be viewed at the link below:
The Science of Practical Application

We will continue to transform scientific innovation into social value and contribute to a better future through the development of innovative technologies and sustainable business growth.